Explore the latest developments concerning Johnson & Johnson.
J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold?
Johnson & Johnson’s JNJ stock has risen 38.4% in the past six months. The stock has also been trading above its 50-day and 200-day simple moving averages (SMAs) for more than eight months since mid-June 2025 due to its positive earnings outlook and improving fundamentals. When the 50-day moving average crosses above the 200-day moving average on a stock’s price chart, it's known as a "golden cross," a bullish signal suggesting potential for a prolonged upward trend. J&J’s 50-day SMA has been above the 200-day SMA since it achieved the golden cross in July, suggesting that the stock is in a sustained uptrend.
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash
Market downturns can be challenging for investors to navigate. But one way to get through them is to own shares of companies that can perform relatively well even when the going gets rough. In that regard, Johnson & Johnson (JNJ +2.04%), a healthcare leader, is a strong option.
Here are two reasons that I'd hold its shares through any market crash.
Healthcare is a defensive industry that's somewhat protected from economic fluctuations. If a market crash occurs due to challenging economic conditions, investors can rest assured that a healthcare giant like Johnson & Johnson will still deliver relatively stable financial results. After all, patients won't want to stop taking life-saving cancer (or other) medicines, nor will physicians stop prescribing them.
Collagen Peptides Types I, II, III, V & X, Biotin Keratin Hyaluronic Acid MSM Vitamins – Skin, Nails & Joint Health, Anti-Aging
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.
For more detailed information, explore updates concerning Johnson & Johnson.
0 Comments